Skip to content

Clinical trials

Phase 4 Graves Ophthalmopathy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Graves Ophthalmopathy Phase: Phase 4 Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20091
20101
20112
20122
20131
20142
20151
20161
20171
20212
20221
20243
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting6
Not yet recruiting4
Unknown status4
Withdrawn2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shanghai Changzheng Hospital3
Amgen2
Ankara University1
Cardiff University1
Dalian University1
Göteborg University1
Innovent Biologics (Suzhou) Co. Ltd.1
Jie Shen1
Medical University of Vienna1
Medical University of Warsaw1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Graves Ophthalmopathy25
Graves Disease4
Bronchiolitis Obliterans Syndrome1
Chemical and Drug Induced Liver Injury1
Exophthalmos1
Glaucoma1
Hepatic Insufficiency1
Hyperthyroidism1
Liver Diseases1
Liver Failure1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.